Abstract: A potato chip having no added fat and process for preparation thereof, wherein a slice of undehydrated fresh potato having no added fat and no coating of globular protein and having a thickness of about 1 to about 3 millimeters is heated in a microwave oven at high intensity, with periodic heating separated by periodic cooling for a period of time sufficient to produce a product having essentially the same flavor, color and crispness as potato slices fried in deep fat. The resulting potato chip has substantially reduced calories as compared with potato chips fried in deep fat or oil, and has essentially the same low fat content as uncooked potatoes. Optionally, the slice may be coated with a non-globular protein coating prior to microwave heating. Such a coating may include salt, non-globular protein, flavorants, spices, and/or vitamin additives, as desired, but preferably does not contain any fat which would increase the fat and calorie content of the finished potato chip.

Abstract: A treatment for accelerating regional weight reduction in humans, wherein an active ingredient encouraging elimination of fatty deposits, preferably a beta adrenergic stimulator or an alpha-2 adrenergic inhibitor, is selectively delivered to a regional fat deposit prior to commencing or during a general weight control program, whereby body weight is preferentially reduced in the selected area. The beta adrenergic stimulator, preferably isoproterenol or forskolin, or the alpha-2 adrenergic inhibitor, preferably yohimbine, or combinations thereof may be delivered by any means accomplishing specific delivery to the selected area, including injection, implantation, and topical application to the skin as in an ointment or creme.

Abstract: A treatment for accelerating regional weight reduction in humans, wherein an active ingredient encouraging elimination of fatty deposits, preferably a beta adrenergic stimulator or an alpha-2 adrenergic inhibitor, is selectively delivered to a regional fat deposit prior to commencing or during a general weight control program, whereby body weight is preferentially reduced in the selected area. The beta adrenergic stimulator, preferably isoproterenol or forskolin, or the alpha-2 adrenergic inhibitor, preferably yohimbine, or combinations thereof may be delivered by any means accomplishing specific delivery to the selected area, including injection, implantation, and topical application to the skin as in an ointment or creme.

Abstract: A power plant and drive system for an automotive vehicle includes a constant speed 120 volt 3 phase AC motor which is coupled to the drive shaft of the vehicle through a magnetic particle clutch. The 120 volt 3 phase AC motor receives energy from a 120 volt AC alternator which is coupled to the motor through a one to three phase converter and connected in tandem to three 12 V DC alternators. The system further includes a battery driven 12 volt DC motor and a 5 cubic inch gas motor. Some of the energy generated by the 12 volt DC alternators is used to recharge the batteries that power the 12 volt DC motor. In normal operation, the alternators are driven solely by the 12 volt DC motor; however, when the voltage in the batteries becomes lower than 6 volts the alternators are driven solely by the gas motor, thus allowing the batteries to recharge to their normal level. Speed control of the vehicle is achieved by varying the coupling strength of the magnetic particle clutch.